ENTAFARMA Plius - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 397,291 | 665,246 | 1,009,679 | 1,544,917 | 1,912,850 | 2,430,967 | 2,801,446 | 3,293,835 |
| Profit before tax | -33,349 | 180,000 | 271,660 | 241,616 | 285,049 | 697,611 | 626,804 | 840,581 |
| Net profit | -33,349 | 171,764 | 235,042 | 203,675 | 239,053 | 588,070 | 527,911 | 697,299 |
| Equity | 11,157 | 182,920 | 417,962 | 621,637 | 860,690 | 978,172 | 917,847 | 1,026,911 |
| Liabilities | 36,310 | 152,138 | 76,747 | 135,956 | 194,104 | 218,007 | 285,252 | 216,036 |
| Non-current assets | 44,313 | 130,783 | 119,858 | 114,462 | 88,578 | 53,853 | 84,772 | 266,419 |
| Current assets | 3,154 | 204,275 | 374,851 | 643,131 | 966,216 | 1,142,326 | 1,118,327 | 964,661 |
| Total assets | 47,467 | 335,058 | 494,709 | 757,593 | 1,054,794 | 1,196,179 | 1,203,099 | 1,231,080 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 732,785 | 836,535 | 963,795 |
| Social insurance contributions | - | - | - | - | - | 223,632 | 244,151 | 261,156 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.6% | +67.4% | +51.8% | +53.0% | +23.8% | +27.1% | +15.2% | +17.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -70.3% | 51.3% | 47.5% | 26.9% | 22.7% | 49.2% | 43.9% | 56.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -298.9% | 93.9% | 56.2% | 32.8% | 27.8% | 60.1% | 57.5% | 67.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.4% | 25.8% | 23.3% | 13.2% | 12.5% | 24.2% | 18.8% | 21.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -8.4% | 27.1% | 26.9% | 15.6% | 14.9% | 28.7% | 22.4% | 25.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.3 | 0.8 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 25,092 | 40,729 | 63,435 | 67,908 | 77,548 | 103,080 | 122,691 | 141,670 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ENTAFARMA Plius - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-07-01 | 0.01 |
| 2026-05-17 | 2026-06-01 | 0.01 |
| 2025-07-24 | 2025-08-03 | 16.70 |
| 2025-04-16 | 2025-04-21 | 8836.91 |
| 2022-09-16 | 2022-09-26 | 1.38 |
| 2022-08-23 | 2022-09-05 | 1.38 |
| 2022-07-25 | 2022-08-02 | 1.38 |
| 2022-05-17 | 2022-06-02 | 255.36 |
| 2021-10-18 | 2021-11-07 | 0.05 |
| 2021-09-16 | 2021-10-03 | 0.05 |
ENTAFARMA Plius - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-09-23 | 2026-09-23 | 10.28 |
| 2026-05-22 | 2026-05-25 | 18.65 |
| 2026-05-08 | 2026-05-21 | 17.71 |
| 2026-05-07 | 2026-05-07 | 19739.25 |
| 2026-03-29 | 2026-04-08 | 7.29 |
| 2026-02-21 | 2026-02-21 | 1.85 |
| 2025-02-26 | 2025-02-26 | 0.08 |
| 2025-02-20 | 2025-02-25 | 24.39 |
| 2024-10-10 | 2024-10-15 | 71.57 |
| 2024-10-01 | 2024-10-09 | 27539.59 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ENTAFARMA Plius, UAB (code 300542655) is a Private Limited Liability Company operating in activities of advertising agencies. In financial year 2025, the company generated revenue of €3.29 million and net profit of €697.3 thousand, with a profit margin of 21.2%. Revenue increased by 17.6% year on year and by 35.5% over two years, showing a steady upward trend from €2.43 million in 2023 to €2.80 million in 2024 and €3.29 million in 2025. Net profit followed a similar pattern, moving from €588.1 thousand in 2023 to €527.9 thousand in 2024 and then recovering to €697.3 thousand in 2025. At year-end 2025, total assets stood at €1.23 million, equity at €1.03 million and liabilities at €216.0 thousand. The equity ratio was 83.4% and debt-to-equity 0.21, indicating a strong balance sheet position. Asset turnover was 2.68x, ROE 67.9% and ROA 56.6%. Revenue per employee was €143.2 thousand and profit per employee €30.3 thousand.